Treg cells play a pivotal role in suppressing tissue inflammation, dependent on the effectors TGF-β and IL-10, while Th17 cells are pro-inflammatory, primarily secreting IL-17A and closely linked to IBD severity (Britton et al., 2019; Yan et al., 2020). Here, TGFB1 is linked to inflammatory bowel disease.